LPL Financial’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Buy |
7,267
+3,787
| +109% | +$654K | ﹤0.01% | 3516 |
|
|
2025
Q1 | $542K | Sell |
3,480
-719
| -17% | -$112K | ﹤0.01% | 4044 |
|
|
2024
Q4 | $578K | Buy |
4,199
+1,577
| +60% | +$217K | ﹤0.01% | 3913 |
|
|
2024
Q3 | $391K | Sell |
2,622
-252
| -9% | -$37.6K | ﹤0.01% | 4139 |
|
|
2024
Q2 | $392K | Buy |
2,874
+296
| +11% | +$40.4K | ﹤0.01% | 3993 |
|
|
2024
Q1 | $390K | Sell |
2,578
-276
| -10% | -$41.7K | ﹤0.01% | 3933 |
|
|
2023
Q4 | $359K | Sell |
2,854
-382
| -12% | -$48.1K | ﹤0.01% | 3887 |
|
|
2023
Q3 | $303K | Sell |
3,236
-597
| -16% | -$55.9K | ﹤0.01% | 3868 |
|
|
2023
Q2 | $342K | Buy |
+3,833
| New | +$342K | ﹤0.01% | 3698 |
|
|
2023
Q1 | – | Sell |
-1,736
| Closed | -$212K | – | 4457 |
|
|
2022
Q4 | $212K | Buy |
+1,736
| New | +$212K | ﹤0.01% | 3908 |
|
|
2022
Q3 | – | Sell |
-2,288
| Closed | -$213K | – | 4384 |
|
|
2022
Q2 | $213K | Sell |
2,288
-55
| -2% | -$5.12K | ﹤0.01% | 3863 |
|
|
2022
Q1 | $275K | Sell |
2,343
-393
| -14% | -$46.1K | ﹤0.01% | 3615 |
|
|
2021
Q4 | $368K | Buy |
2,736
+555
| +25% | +$74.6K | ﹤0.01% | 3528 |
|
|
2021
Q3 | $348K | Sell |
2,181
-117
| -5% | -$18.7K | ﹤0.01% | 3512 |
|
|
2021
Q2 | $302K | Buy |
2,298
+25
| +1% | +$3.29K | ﹤0.01% | 3567 |
|
|
2021
Q1 | $293K | Sell |
2,273
-50
| -2% | -$6.45K | ﹤0.01% | 3466 |
|
|
2020
Q4 | $387K | Sell |
2,323
-206
| -8% | -$34.3K | ﹤0.01% | 2970 |
|
|
2020
Q3 | $390K | Buy |
2,529
+21
| +0.8% | +$3.24K | ﹤0.01% | 2668 |
|
|
2020
Q2 | $371K | Sell |
2,508
-10
| -0.4% | -$1.48K | ﹤0.01% | 2650 |
|
|
2020
Q1 | $284K | Buy |
+2,518
| New | +$284K | ﹤0.01% | 2535 |
|
|
2019
Q3 | – | Sell |
-2,233
| Closed | -$257K | – | 3284 |
|
|
2019
Q2 | $257K | Buy |
2,233
+131
| +6% | +$15.1K | ﹤0.01% | 2816 |
|
|
2019
Q1 | $247K | Buy |
+2,102
| New | +$247K | ﹤0.01% | 2771 |
|